Hospital Clinic Institute dInvestigacio Biomedica August Pi i Sunyer IDIBAPS

Barcelona, Spain

Hospital Clinic Institute dInvestigacio Biomedica August Pi i Sunyer IDIBAPS

Barcelona, Spain

Time filter

Source Type

PubMed | Hospital Clinic Institute dInvestigacio Biomedica August Pi i Sunyer IDIBAPS, Massachusetts General Hospital and Cellex, Inc.
Type: Journal Article | Journal: Seminars in neurology | Year: 2014

In the past few years, many autoimmune encephalitides have been identified, with specific clinical syndromes and associated antibodies against neuronal surface antigens. There is compelling evidence that many of these antibodies are pathogenic and most of these encephalitides are highly responsive to immunotherapies. The clinical spectra of some of these antibody-mediated syndromes, especially those reported in only a few patients, are evolving. Others, such as anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, are well characterized. Diagnosis involves recognizing the specific syndromes and identifying the antibody in a patients cerebrospinal fluid (CSF) and/or serum. These syndromes are associated with variable abnormalities in CSF, magnetic resonance imaging, and electroencephalography. Treatment is often multidisciplinary and should be focused upon neutralizing the effects of antibodies and eliminating their source. Overlapping disorders have been noted, with some patients having more than one neurologic autoimmune disease. In other patients, viral infections such as herpes simplex virus encephalitis trigger robust antineuronal autoimmune responses.

Loading Hospital Clinic Institute dInvestigacio Biomedica August Pi i Sunyer IDIBAPS collaborators
Loading Hospital Clinic Institute dInvestigacio Biomedica August Pi i Sunyer IDIBAPS collaborators